PMI (Picard Medical) ROCE %: -2,522.29% (As of Mar. 2026)


PMI Picard Medical Inc PMI
4 GF Score
Price $0.16
! 4 Warning Signs
View Full Analysis

What is Picard Medical ROCE %?

Picard Medical PMI -5.88% 4 ROCE % is -2,522.29% as of Mar. 2026. GuruFocus rates PMI with a GF Score™ of 4/100. The stock has 4 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Picard Medical's annualized ROCE % for the quarter that ended in Mar. 2026 was -2,522.29%.

Picard Medical  (AMEX:PMI) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Picard Medical ROCE % Related Terms

Picard Medical ROCE % Historical Data

* Premium members only.

The historical data trend for Picard Medical's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Picard Medical ROCE % Chart

Picard Medical Annual Data
Trend Dec22 Dec23 Dec24 Dec25
ROCE %
-89.64 -211.34 0.00 0.00

Picard Medical Quarterly Data
Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 -285.31 -2,522.29
PMI
4GF Score
Picard Medical Inc PMI
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Picard Medical ROCE % Calculation

Picard Medical's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=-21.574/( ( (12.106 - 35.325) + (22.548 - 18.695) )/ 2 )
=-21.574/( (-23.219+3.853)/ 2 )
=-21.574/-9.683
=222.80 %

Picard Medical's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=-30.444/( ( (22.548 - 18.695) + (11.22 - 12.659) )/ 2 )
=-30.444/( ( 3.853 + -1.439 )/ 2 )
=-30.444/1.207
=-2,522.29 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -2,522.29% mean?
Picard Medical (PMI) has a ROCE % of -2,522.29% as of Mar. 2026.
Is Picard Medical's ROCE % too high?
Picard Medical's current ROCE % is -2,522.29%. Overall, Picard Medical has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does Picard Medical's ROCE % compare to TRIB and NXL?
Picard Medical's ROCE % of -2,522.29% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.23. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Devices & Instruments company?
The median ROCE % among Medical Devices & Instruments companies is 2.23, based on 814 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Picard Medical's current ROCE % is -2,522.29%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Picard Medical stock overvalued right now?
Picard Medical (PMI) has a current ROCE % of -2,522.29%. The current ROCE % is -2,522.29%. Picard Medical's overall GF Score™ is 4/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Picard Medical (PMI), the current ROCE % is -2,522.29% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Picard Medical Business Description

Address 1992 East Silverlake, Tucson, AZ, USA, 85713
Picard Medical Inc operates through its wholly owned subsidiary, a medical technology company focused on developing, manufacturing, and commercializing the SynCardia TAH, an implantable total artificial heart system. The company is engaged in designing, manufacturing, producing, supplying, marketing, and selling medical device products, including the SynCardia TAH, which is designed to assume the full function of a failed human heart in patients suffering from advanced heart failure. The SynCardia TAH replaces both the left and right ventricles as well as all four heart valves.
4GF Score

Get the complete analysis for PMI

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.16
Price